Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check3 days agoChange DetectedRevision indicator updated to v3.4.3; references to Melanoma, MedlinePlus Genetics, and Revision: v3.4.2 were removed.SummaryDifference0.2%

- Check10 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 was added, and the page removed the funding-status notice, Melanoma topic, related topics, and the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check38 days agoChange DetectedAdded a site-wide notice about government funding impact and operational status; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check46 days agoChange DetectedMinor UI/copy updates: glossary toggle text is added, labels are capitalized to read 'Last Update Submitted that Met QC Criteria', and the footer shows 'Revision: v3.4.0' with adjusted 'No FEAR Act Data' capitalization.SummaryDifference0.2%

- Check53 days agoChange DetectedMelanoma has been added to the related topics, and MedlinePlus Genetics is now listed under related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.